Channing Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Channing Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-145,217	Closed	-$10.3M	–	110
2022 Q3	$10.3M	Buy	145,217 +18,693	+15%	+$1.36M	0.36%	59
2022 Q2	$9.74M	Sell	126,524 -26,366	-17%	-$2.01M	0.32%	67
2022 Q1	$11.2M	Sell	152,890 -22,812	-13%	-$1.53M	0.33%	68
2021 Q4	$11M	Buy	175,702 +159	+0.1%	+$9.33K	0.31%	77
2021 Q3	$10.4M	Buy	175,543 +9,976	+6%	+$657K	0.32%	80
2021 Q2	$11.1M	Buy	165,567 +38,011	+30%	+$2.48M	0.36%	84
2021 Q1	$8.05M	Buy	127,556 +10,598	+9%	+$659K	0.27%	92
2020 Q4	$7.25M	Buy	116,958 +30,907	+36%	+$1.9M	0.3%	87
2020 Q3	$5.19M	Sell	86,051 -3,931	-4%	-$237K	0.28%	90
2020 Q2	$5.29M	Sell	89,982 -10,999	-11%	-$658K	0.3%	87
2020 Q1	$5.63M	Sell	100,981 -31,095	-24%	-$1.9M	0.4%	63
2019 Q4	$8.48M	Sell	132,076 -56,358	-30%	-$3.23M	0.39%	74
2019 Q3	$9.55M	Buy	188,434 +10,512	+6%	+$494K	0.44%	60
2019 Q2	$8.07M	Buy	177,922 +38,938	+28%	+$1.81M	0.37%	68
2019 Q1	$6.63M	Sell	138,984 -19,765	-12%	-$985K	0.31%	77
2018 Q4	$8.25M	Sell	158,749 -6,631	-4%	-$356K	0.41%	58
2018 Q3	$10.3M	Buy	165,380 +1,866	+1%	+$111K	0.37%	53
2018 Q2	$9.05M	Buy	163,514 +77,691	+91%	+$4.2M	0.32%	71
2018 Q1	$5.43M	Buy	85,823 +122	+0.1%	+$7.85K	0.19%	88
2017 Q4	$5.25M	Hold	85,701	–	–	0.18%	92
2017 Q3	$5.46M	Buy	+85,701	New	+$5M	0.21%	89

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Channing Capital Management's BMY Position: Q4 2022 in Review

Channing Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 145,217 shares — an estimated $10.3M sold.

Channing Capital Management first reported a position in BMY in Q3 2017 and held it in 21 quarters. The position peaked at $11.2M in Q1 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Channing Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Channing Capital Management sold 145,217 Bristol-Myers Squibb shares in Q4 2022, an estimated $10.3M.
Channing Capital Management first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 21 quarters.
Channing Capital Management's Bristol-Myers Squibb position peaked at $11.2M in Q1 2022.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Channing Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.